title: Selective inhibition of the K(ir)2 family of inward rectifier potassium channels by a small molecule probe: the discovery, SAR, and pharmacological characterization of ML133.
abstract: The K(ir) inward rectifying potassium channels have a broad tissue distribution and are implicated in a variety of functional roles. At least seven classes (K(ir)1-K(ir)7) of structurally related inward rectifier potassium channels are known, and there are no selective small molecule tools to study their function. In an effort to develop selective K(ir)2.1 inhibitors, we performed a high-throughput screen (HTS) of more than 300,000 small molecules within the MLPCN for modulators of K(ir)2.1 function. Here we report one potent K(ir)2.1 inhibitor, ML133, which inhibits K(ir)2.1 with an IC(50) of 1.8 μM at pH 7.4 and 290 nM at pH 8.5 but exhibits little selectivity against other members of Kir2.x family channels. However, ML133 has no effect on K(ir)1.1 (IC(50) > 300 μM) and displays weak activity for K(ir)4.1 (76 μM) and K(ir)7.1 (33 μM), making ML133 the most selective small molecule inhibitor of the K(ir) family reported to date. Because of the high homology within the K(ir)2 family-the channels share a common design of a pore region flanked by two transmembrane domains-identification of site(s) critical for isoform specificity would be an important basis for future development of more specific and potent K(ir) inhibitors. Using chimeric channels between K(ir)2.1 and K(ir)1.1 and site-directed mutagenesis, we have identified D172 and I176 within M2 segment of K(ir)2.1 as molecular determinants critical for the potency of ML133 mediated inhibition. Double mutation of the corresponding residues of K(ir)1.1 to those of K(ir)2.1 (N171D and C175I) transplants ML133 inhibition to K(ir)1.1. Together, the combination of a potent, K(ir)2 family selective inhibitor and identification of molecular determinants for the specificity provides both a tool and a model system to enable further mechanistic studies of modulation of K(ir)2 inward rectifier potassium channels.
authors: Department of Neuroscience, High Throughput Biology Center and Johns Hopkins Ion Channel Center, School of Medicine, Johns Hopkins University, 733 North Broadway, Baltimore, Maryland 21205, United States.
authors: Hao-Ran
authors: HR
authors: Wang
authors: Meng
authors: M
authors: Wu
authors: Haibo
authors: H
authors: Yu
authors: Shunyou
authors: S
authors: Long
authors: Amy
authors: A
authors: Stevens
authors: Darren W
authors: DW
authors: Engers
authors: Henry
authors: H
authors: Sackin
authors: J Scott
authors: JS
authors: Daniels
authors: Eric S
authors: ES
authors: Dawson
authors: Corey R
authors: CR
authors: Hopkins
authors: Craig W
authors: CW
authors: Lindsley
authors: Min
authors: M
authors: Li
authors: Owen B
authors: OB
authors: McManus
references: Neurology. 2005 Oct 11;65(7):1083-9
references: 16217063
references: Eur J Pharmacol. 2010 Jul 25;638(1-3):33-41
references: 20447386
references: J Comput Chem. 2004 Oct;25(13):1605-12
references: 15264254
references: Neuron. 2010 Jan 14;65(1):32-9
references: 20152111
references: Nat Rev Neurosci. 2006 Mar;7(3):194-206
references: 16495941
references: FASEB J. 1999 Nov;13(14):1901-10
references: 10544173
references: Neuron. 2001 Mar;29(3):657-67
references: 11301025
references: Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1364-8
references: 18216262
references: Mol Pharmacol. 2009 Nov;76(5):1094-103
references: 19706730
references: J Physiol. 2003 Nov 15;553(Pt 1):101-12
references: 12963788
references: Mol Pharmacol. 2004 Jan;65(1):214-9
references: 14722253
references: J Biol Chem. 2009 Jun 5;284(23):15432-8
references: 19366693
references: Mol Pharmacol. 2011 Jan;79(1):42-50
references: 20926757
references: J Mol Biol. 1993 Mar 20;230(2):543-74
references: 8464064
references: Neuron. 2009 Feb 26;61(4):519-26
references: 19249273
references: Science. 1998 Apr 3;280(5360):69-77
references: 9525859
references: J Comb Chem. 2008 May-Jun;10(3):345-54
references: 18220367
references: Diabetologia. 2008 May;51(5):802-10
references: 18335204
references: Physiol Rev. 2010 Jan;90(1):291-366
references: 20086079
references: FEBS Lett. 2002 Nov 6;531(2):250-4
references: 12417321
references: J Cardiovasc Pharmacol. 2008 Aug;52(2):129-35
references: 18670367
references: J Pharmacol Exp Ther. 2009 Nov;331(2):563-73
references: 19654266
references: Neuron. 2000 Apr;26(1):35-43
references: 10798390
references: J Gen Physiol. 2005 Apr;125(4):413-26
references: 15795311
references: J Biomol Screen. 2003 Dec;8(6):634-47
references: 14711389
references: Pharmacol Rev. 2005 Dec;57(4):509-26
references: 16382105
references: Circ Res. 2005 Apr 15;96(7):703-4
references: 15831819
references: Biophys J. 2004 Apr;86(4):2145-55
references: 15041655
references: Cell Biochem Biophys. 2007;47(2):209-56
references: 17652773
references: Jpn J Pharmacol. 2001 Sep;87(1):1-6
references: 11676192
references: Science. 2009 Dec 18;326(5960):1668-74
references: 20019282
references: Neuron. 1999 Mar;22(3):571-80
references: 10197536
references: J Biol Chem. 2006 Mar 3;281(9):5877-84
references: 16407206
references: J Clin Invest. 2002 Aug;110(3):381-8
references: 12163457
references: Future Med Chem. 2010 May;2(5):757-74
references: 20543968